亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

医学 重症监护医学 梅德林 生物 生物化学
作者
Helen W. Boucher,George H. Talbot,John S. Bradley,John E. Edwards,David N. Gilbert,Louis B. Rice,Michael Scheld,Brad Spellberg,John Bartlett
出处
期刊:Clinical Infectious Diseases [Oxford University Press]
卷期号:48 (1): 1-12 被引量:4618
标识
DOI:10.1086/595011
摘要

The Infectious Diseases Society of America (IDSA) continues to view with concern the lean pipeline for novel therapeutics to treat drug-resistant infections, especially those caused by gram-negative pathogens. Infections now occur that are resistant to all current antibacterial options. Although the IDSA is encouraged by the prospect of success for some agents currently in preclinical development, there is an urgent, immediate need for new agents with activity against these panresistant organisms. There is no evidence that this need will be met in the foreseeable future. Furthermore, we remain concerned that the infrastructure for discovering and developing new antibacterials continues to stagnate, thereby risking the future pipeline of antibacterial drugs. The IDSA proposed solutions in its 2004 policy report, "Bad Bugs, No Drugs: As Antibiotic R&D Stagnates, a Public Health Crisis Brews", and recently issued a "Call to Action" to provide an update on the scope of the problem and the proposed solutions. A primary objective of these periodic reports is to encourage a community and legislative response to establish greater financial parity between the antimicrobial development and the development of other drugs. Although recent actions of the Food and Drug Administration and the 110th US Congress present a glimmer of hope, significant uncertainly remains. Now, more than ever, it is essential to create a robust and sustainable antibacterial research and development infrastructure—one that can respond to current antibacterial resistance now and anticipate evolving resistance. This challenge requires that industry, academia, the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control and Prevention, the US Department of Defense, and the new Biomedical Advanced Research and Development Authority at the Department of Health and Human Services work productively together. This report provides an update on potentially effective antibacterial drugs in the late-stage development pipeline, in the hope of encouraging such collaborative action.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xuan发布了新的文献求助10
2秒前
喂喂喂完成签到,获得积分10
3秒前
田様应助酷酷朋友采纳,获得10
8秒前
22秒前
25秒前
酷酷朋友发布了新的文献求助10
27秒前
32秒前
华仔应助纯洁采纳,获得10
40秒前
风起云涌龙完成签到 ,获得积分0
41秒前
56秒前
Parahaz发布了新的文献求助10
1分钟前
1分钟前
xiaoze发布了新的文献求助80
1分钟前
传奇3应助Parahaz采纳,获得10
1分钟前
kiko完成签到 ,获得积分10
1分钟前
1分钟前
NexusExplorer应助等待的花生采纳,获得10
1分钟前
Parahaz完成签到,获得积分20
1分钟前
HEXIAO发布了新的文献求助10
1分钟前
传奇3应助norberta采纳,获得10
1分钟前
1分钟前
1分钟前
善学以致用应助Cherry采纳,获得10
1分钟前
LONG完成签到 ,获得积分10
1分钟前
科目三应助xiaoze采纳,获得10
1分钟前
yfe完成签到 ,获得积分10
2分钟前
lmc发布了新的文献求助10
2分钟前
土书发布了新的文献求助10
2分钟前
xiaoze完成签到,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
2分钟前
2分钟前
orixero应助xuan采纳,获得10
2分钟前
Aurora发布了新的文献求助10
2分钟前
2分钟前
fengliurencai完成签到,获得积分10
2分钟前
xuan完成签到,获得积分20
2分钟前
纯洁发布了新的文献求助10
2分钟前
共享精神应助小全采纳,获得10
2分钟前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Very-high-order BVD Schemes Using β-variable THINC Method 850
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3248737
求助须知:如何正确求助?哪些是违规求助? 2892201
关于积分的说明 8270138
捐赠科研通 2560300
什么是DOI,文献DOI怎么找? 1388970
科研通“疑难数据库(出版商)”最低求助积分说明 650927
邀请新用户注册赠送积分活动 627850